Alcon Inc.
Alcon Inc.
- Market cap
- $35.70B
- P/E ratio
- 54.83
Your view on ALC
Overview
What the company does, where it operates, and who runs it.
About Alcon Inc.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- David J. Endicott
- Headquarters
- Chemin de Blandonnet 8, Geneva, CH
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- David J. Endicott
- Headquarters
- Chemin de Blandonnet 8, Geneva, CH
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.
The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures.
Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery.
Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands.
The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Alcon Inc. from FRC's valuation model, read against the market price. ALC last traded at $74.31, 54.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Alcon Inc.. Starting points for Alcon Inc.: P/E 54.8, EPS $1.38, beta 0.72 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Alcon Inc.. Alcon Inc. paid $0.36 per share over the last year — a 0.5% yield at the current $74.31 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Alcon Inc.. Trailing twelve-month EPS for Alcon Inc. stands at $1.38. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Targets, low to high
Analyst ratings
11 firms, last 12 months- Strong Buy0
- Buy7
- Hold3
- Sell1
- Strong Sell0
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $0.88 | $0.92 | $3.43 | $3.81 |
| Lowest estimate | $0.85 | $0.88 | $3.42 | $3.66 |
| Highest estimate | $0.93 | $1.05 | $3.46 | $3.95 |
| Number of analysts | 8 | 3 | 15 | 16 |
| A year ago | $0.78 | $0.85 | $1.98 | — |
| Growth vs a year ago | +13.3% | +8.6% | +73.5% | — |
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $2.79B | $2.78B | $10.89B | $11.49B |
| Lowest estimate | $2.78B | $2.68B | $10.86B | $11.44B |
| Highest estimate | $2.80B | $3.06B | $10.97B | $11.54B |
| Number of analysts | 4 | 2 | 14 | 17 |
| A year ago | $2.72B | $2.65B | $10.40B | — |
| Growth vs a year ago | +2.8% | +4.6% | +4.7% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Alcon Inc.. Alcon Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| BLCOBausch + Lomb Corporation | Healthcare | Medical - Instruments & Supplies | $6.9B | ||
| COOThe Cooper Companies, Inc. | Healthcare | Medical - Instruments & Supplies | $11.2B | ||
| ESLOYEssilorLuxottica S.A. | Healthcare | Medical - Instruments & Supplies | $129.8B | ||
| GKOSGlaukos Corporation | Healthcare | Medical - Devices | $14.0B | ||
| HOCPFHOYA Corporation | Healthcare | Medical - Instruments & Supplies | $64.6B | ||
| IRIXIRIDEX Corporation | Healthcare | Medical - Devices | $7.9M | ||
| LNSRLENSAR, Inc. | Healthcare | Medical - Devices | $54.8M | ||
| RXSTRxSight, Inc. | Healthcare | Medical - Devices | $187.4M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| UAHCUnited American Healthcare Corporation | Healthcare | OTC | $1.1M | ||
| UEECUnited Health Products, Inc. | Healthcare | OTC | $14.9M | ||
| VFY.AXVitrafy Life Sciences Ltd. | Healthcare | ASX | — | ||
| VMTHFVenus Medtech (Hangzhou) Inc. | Healthcare | OTC | $184.7M | ||
| VVVVvVARDIS HOLDING AG Class A | Healthcare | NYSE | $558.7M | ||
| WCUIWellness Center USA, Inc. | Healthcare | OTC | $13,063 | ||
| WOKWORK Medical Technology Group Ltd. | Healthcare | NASDAQ | $4.8M | ||
| YPHDFYpsomed Holding AG | Healthcare | OTC | $5.2B | ||
| ACAISafeplus International Holdings Limited | Healthcare | OTC | $477 | ||
| ADLIAmerican Medical Technologies Inc. | Healthcare | OTC | $1,031 | ||
| AIMVAI Maverick Intel, Inc. | Healthcare | OTC | $3.0M | ||
| ANIKAnika Therapeutics, Inc. | Healthcare | NASDAQ | $177.2M | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| EQTYKovitz Core Equity ETF | $1.4B in assets | 3.06% | |
| DFIVDimensional - International Value ETF | $22.0B in assets | 0.17% | |
| DFAIDimensional - International Core Equity Market ETF | $17.9B in assets | 0.12% | |
| DFICDimensional - International Core Equity 2 ETF | $15.4B in assets | 0.10% | |
| YLDWWestwood Enhanced Income Opport | $43M in assets | 1.31% | |
| HRTSTema Cardiovascular and Metabolic ETF | $58M in assets | 1.06% | |
| IMFLInvesco International Developed Dynamic Multifactor ETF | $1.1B in assets | 0.19% | |
| QDX.TOMackenzie International Equity Index ETF | $2.1B in assets | 0.17% | |
Largest holders first, then the funds most concentrated in ALC.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Alcon Inc., and how their positions are changing. At a $35.70B market value, institutional positions materially move Alcon Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Alcon Inc.. Alcon Inc. is a $35.70B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Alcon Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Alcon Inc.. Coverage tracks Alcon Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Alcon Inc.